Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 3, 2006, Pages 1112-1117

  Pankuch, Glenn A ^a   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CLINDAMYCIN; DENITROTIZOXANIDE; METRONIDAZOLE; NITAZOXANIDE; RM 4803; RM 4807; RM 4809; RM 4819; THIAZOLE DERIVATIVE; TIZOXANIDE; UNCLASSIFIED DRUG;

AGAR DILUTION; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON; CLOSTRIDIUM DIFFICILE; DILUTION; DRUG STRUCTURE; EGGERTHELLA LENTA; EUBACTERIUM; FUSOBACTERIUM NECROPHORUM; FUSOBACTERIUM NUCLEATUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PORPHYROMONAS; PREVOTELLA; PREVOTELLA BIVIA; PREVOTELLA DISIENS; PREVOTELLA INTERMEDIA; PREVOTELLA MELANINOGENICA; PRIORITY JOURNAL;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; CLINDAMYCIN; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; THIAZOLES;

EID: 33644653117     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.3.1112-1117.2006     Document Type: Article

References (11)

1. Bartlett, J. G. 1992. Antibiotic-associated diarrhea. Clin. Infect. Dis. 15:573-581.
2. Dubreuil, L., I. Houck, Y. Mouton, and J. F. Rossini. 1996. In vitro evaluation of activities of nitazoxanide and tizoxanide against anaerobes and aerobic organisms. Antimicrobial. Agents Chemotherapy 40:2266-2270.
3. Ednie, L M, A. Rattan, M. R. Jacobs, and P. C. Appelbaum. 2003. Antianaerobic activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents. Antimicrob. Agents Chemother. 47:1143-1147.
4. Fox, L. M., and L. D. Saravolatz. 2005. Nitazoxanide: a new thiazolide antiparasitic agent. Clin. Infect. Dis. 40:1173-1180.
5. Guerrant, R. L., J. M. Hughes, N. L. Lima, and J. Crane. 1990. Diarrhea in developed and developing countries: magnitude, special settings and etiologies. Rev. Infect. Dis. 12(Suppl. 1):S41-S50.
6. Guttner, Y., H. M. Windsor, C. H. Viiala, L. Dusci, and B. J. Marshall. 2003. Nitazoxanide in treatment of Helicobacter pylori: a clinical and in vitro study. Antimicrob. Agents Chemother. 47:3780-3783.
7. Jousimies-Somer, H. R., P. Summanen, D. M. Citron, E. J. Baron, H. M. Wexler, and S. M. Finegold. 2002. Wadsworth-KTL anaerobic bacteriology manual, 6th ed. Star Publishing Co., Belmont, Calif.
8. Murray, P. R., E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.) 2003. Manual of clinical microbiology, 8th ed. American Society for Microbiology, Washington, D.C.
9. National Committee for Clinical Laboratory Standards. 2004. Methods for antimicrobial susceptibility testing of anaerobic bacteria-sixth edition; approved standard. NCCLS publication no. M11-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Pearson, R. D. 2004. Nitazoxanide as treatment of intestinal parasites in children. Curr. Infect. Dis. Rep. 6:25-26.
11. Pépin, J., M.-E. Alary, L. Valiquette, E. Raiche, J. Ruel, K. Fulop, D. Godin, and C. Bourassa. 2005. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin. Infect. Dis. 40:1591-1597.